Skip to main content
NCBI home page
Gut logoLink to Gut
. 1985 Feb;26(2):212–214. doi: 10.1136/gut.26.2.212

Acute delta hepatitis without circulating HBsAg.

K M De Cock, S Govindarajan, A G Redeker
PMCID: PMC1432425  PMID: 3967840

Abstract

Infection with the delta agent can only occur in the context of coexistent hepatitis B virus infection. We describe a patient in whom the clinical features of acute delta hepatitis developed when seroconversion from hepatitis B surface antigen to antibody had already occurred and diagnosis of recent acute hepatitis B was based on high titre IgM antibody to hepatitis B core antigen. We discuss the significance of such a serological profile, not previously described.

Full text

PDF
212

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonino F., Hoyer B., Ford E., Shih J. W., Purcell R. H., Gerin J. L. The delta agent: HBsAg particles with delta antigen and RNA in the serum of an HBV carrier. Hepatology. 1981 Mar-Apr;1(2):127–131. doi: 10.1002/hep.1840010207. [DOI] [PubMed] [Google Scholar]
  2. Cohen B. J. The IgM antibody responses to the core antigen of hepatitis B virus. J Med Virol. 1978;3(2):141–149. doi: 10.1002/jmv.1890030208. [DOI] [PubMed] [Google Scholar]
  3. Frommel D., Allain J. P., Courouce A. M., Derose S., Trepo D., Crivelli O., Rizzetto M. Long-lasting abatement of HBsAg synthesis induced by acute delta infection. Lancet. 1983 Mar 19;1(8325):656–657. doi: 10.1016/s0140-6736(83)91835-4. [DOI] [PubMed] [Google Scholar]
  4. Gimson A. E., Tedder R. S., White Y. S., Eddleston A. L., Williams R. Serological markers in fulminant hepatitis B. Gut. 1983 Jul;24(7):615–617. doi: 10.1136/gut.24.7.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Govindarajan S., Chin K. P., Redeker A. G., Peters R. L. Fulminant B viral hepatitis: role of delta agent. Gastroenterology. 1984 Jun;86(6):1417–1420. [PubMed] [Google Scholar]
  6. Moestrup T., Hansson B. G., Widell A., Nordenfelt E. Clinical aspects of delta infection. Br Med J (Clin Res Ed) 1983 Jan 8;286(6359):87–90. doi: 10.1136/bmj.286.6359.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Rizzetto M., Canese M. G., Aricò S., Crivelli O., Trepo C., Bonino F., Verme G. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut. 1977 Dec;18(12):997–1003. doi: 10.1136/gut.18.12.997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Rizzetto M., Canese M. G., Gerin J. L., London W. T., Sly D. L., Purcell R. H. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis. 1980 May;141(5):590–602. doi: 10.1093/infdis/141.5.590. [DOI] [PubMed] [Google Scholar]
  9. Rizzetto M., Shih J. W., Gocke D. J., Purcell R. H., Verme G., Gerin J. L. Incidence and significance of antibodies to delta antigen in hepatitis B virus infection. Lancet. 1979 Nov 10;2(8150):986–990. doi: 10.1016/s0140-6736(79)92561-3. [DOI] [PubMed] [Google Scholar]
  10. Rizzetto M. The delta agent. Hepatology. 1983 Sep-Oct;3(5):729–737. doi: 10.1002/hep.1840030518. [DOI] [PubMed] [Google Scholar]
  11. Smedile A., Farci P., Verme G., Caredda F., Cargnel A., Caporaso N., Dentico P., Trepo C., Opolon P., Gimson A. Influence of delta infection on severity of hepatitis B. Lancet. 1982 Oct 30;2(8305):945–947. doi: 10.1016/s0140-6736(82)90156-8. [DOI] [PubMed] [Google Scholar]
  12. Smedile A., Lavarini C., Crivelli O., Raimondo G., Fassone M., Rizzetto M. Radioimmunoassay detection of IgM antibodies to the HBV-associated delta (delta) antigen:" clinical significance in delta infection. J Med Virol. 1982;9(2):131–138. doi: 10.1002/jmv.1890090208. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES